Withdrawal of Correction: Chamaejasmin B Reduces Malignant Traits in Mouse Melanoma B16F0 and B16F10 Cell Lines - Takeaways - MDSpire

Withdrawal of Correction: Chamaejasmin B Reduces Malignant Traits in Mouse Melanoma B16F0 and B16F10 Cell Lines

  • April 27, 2026

  • 0 min

Share

  • 1

    The article titled 'Chamaejasmin B Reduces Malignant Traits in Mouse Melanoma B16F0 and B16F10 Cell Lines' has been retracted.

  • 2

    Concerns were raised regarding the integrity of figures and ethical oversight of animal experiments in the study.

  • 3

    The authors acknowledged that tumor sizes exceeded internationally accepted animal welfare limits.

  • 4

    The experiments conducted did not adhere to the approval from the Shihezi University Animal Care and Use Committee.

  • 5

    The retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers.

Original Source(s)

Withdrawal of Correction: Chamaejasmin B Reduces Malignant Traits in Mouse Melanoma B16F0 and B16F10 Cell Lines

  • April 27, 2026

Related Content

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer